Joseph hill

Chief of Cardiology, UT Southwestern, @UTSWNews
Editor-in-Chief of @CircAHA

[Circulation @CircAHA]

NAP is a key circulating metabolite linking intestinal injury to cardiac toxicity and provides a potential biomarker for monitoring cardiovascular risk in microplastic exposed populations. https://t.co/YePUpEJJvJ

[Circulation @CircAHA]

In this sham-controlled trial of 60 patients with symptomatic atrial fibrillation, pulsed field ablation (PFA) was superior to sham in reducing arrhythmia recurrence & burden and improving QOL. https://t.co/iZqzeZILK7

[Circulation @CircAHA]

Upregulated BACH1 is involved in pulmonary hypertension pathogenic mechanisms. BACH1 inhibition may be a novel therapeutic strategy for idiopathic PAH @eosto1 @jiayi Lin https://t.co/dc5Ou5jyWB

[Circulation @CircAHA]

Integrated single-nuclei and spatial mapping of cardiac sarcoidosis reveal inflammatory niches and clonal B-cell autoimmunity. https://t.co/LS5db1ADTC

[Circulation @CircAHA]

Lifestyle intervention-induced visceral adipose tissue (VAT) loss may persist despite weight regain and confer lasting cardiometabolic benefits: VAT loss, not weight loss, may be the key target for durable cardiometabolic health. https://t.co/uHef45YF0d

[Circulation @CircAHA]

Role of Physical Activity in Obesity Treatment and Cardiometabolic Health
https://t.co/MhD2zw7g7c

[Circulation @CircAHA]

#ICYMI: Recovery from Heart Failure @hfdocbhimaraj
@kaifu3

[Circulation @CircAHA]

#ICYMI: Mechanisms of MINOCA @nyulangone
@BaineyKevin @SripalBangalore
@yadersandoval @aklfahed
@HashimHayder

[Circulation @CircAHA]

#ICYMI: AI-Echo to Detect Congenital Heart Disease @jmayour @sgcard

[Circulation @CircAHA]

#ICYMI: PRMT3-PCSK9 axis amplifies CAVD

[Circulation @CircAHA]

Anticoagulation stewardship care mode: population health approach to identify pts likely to benefit from pharmacist engagement. Other CV medication stewardship services can integrate similar dashboards, alerts, risk stratification algorithms https://t.co/00RvTwhDQu

[Circulation @CircAHA]

#ResearchLetter: In this sub study from the NOTION-3 randomized trial, baseline angina did not modify the relative effect of PCI vs. OMT in patients undergoing TAVI with significant CAD. https://t.co/aRXp86Nga7

[Circulation @CircAHA]

#JustPublished: Lp(a), Evolocumab & First Major Coronary Event https://t.co/vTZNqlOR3f

[Rick Wilson @TheRickWilson]

That's so cruel. No one should repost this over 100 times.

[Circulation @CircAHA]

#Editorial: Che et al show that HEV (high endothelial venules) targeted antibody-drug conjugate can promote long-term cardiac allograft acceptance. https://t.co/GRxMoUlXLx

[Circulation @CircAHA]

#ResearchLetter: Authors demonstrate utilization of Cas13-mediated RNA base editing for treatment of hereditary HCM in a mouse model. https://t.co/TGsSwN4q0f

[Circulation @CircAHA]

@JCigarroaMD

[Circulation @CircAHA]

#On my mind: Recovery for patients with cardiogenic shock with multidisciplinary teams, standardized infrastructure, transparent metrics, and shared responsibility https://t.co/wcE5P8oeMB

[Circulation @CircAHA]

@AndreZimerman, @PrakritiGaba, @TIMIStudyGroup
@DrM_ODonoghue
@rgiuglaino
@AndreZimerman
@zbigniew.gaciong
@marstonMD
@josehfloresmd
@Saraiva@ipec

[Circulation @CircAHA]

#Research letter: Earlier initiation of the PCSK9 inhibitor Evolocumab reduced the risk of arterial aneurysm events compared with delayed initiation in an analysis of the FOURIER trial https://t.co/OaIfeZzb58